Moreover, Shen et al. (2018) reported a decreased pain degree in obese BC patients (BMI > 30 kg/m2) suffering from aromatase inhibitor‐related arthralgia after omega‐3 FAs supplementation (3.3 g/day) for 24 weeks. Here, CYP19A1 is linked to breast cancer.